Review
doi: 10.1016/j.drudis.2016.08.004. Epub 2016 Aug 6.Predisposing factors, pathogenesis and therapeutic intervention of Kawasaki disease
Affiliations
- PMID:27506874
- PMCID: PMC7185772
- DOI: 10.1016/j.drudis.2016.08.004
Item in Clipboard
Review
Predisposing factors, pathogenesis and therapeutic intervention of Kawasaki disease
Caroline Galeotti et al. Drug Discov Today.2016 Nov.
Display options
Format
Display options
Format
Abstract
Kawasaki disease (KD) is an acute febrile childhood inflammatory disease, associated with coronary artery abnormalities. The disease is believed to result from an aberrant inflammatory response to an infectious trigger in a genetically predisposed individual. KD is associated with an endothelial cell injury as a consequence of T cell activation and cytotoxic effects of various proinflammatory cytokines. Intravenous immunoglobulin (IVIG) infusion and aspirin are the standard treatment of acute KD. However, 10-20% of patients show resistance to IVIG therapy and present higher risk of coronary vasculitis. The relative roles of second IVIG infusion, corticosteroids, calcineurin inhibitors, interleukin-1 antagonists and anti-tumor necrosis factor agents remain uncertain. In this review, we highlight the predisposing factors, pathogenesis and therapeutic intervention of KD, particularly new therapeutics for IVIG-resistant patients.
Copyright © 2016 Elsevier Ltd. All rights reserved.
Figures
Pathogenesis of Kawasaki disease. It was proposed that an infectious trigger activates TLR and induces accumulation of pro-IL-1β. ITPKC controls Ca2+ homeostasis by phosphorylating IP3 and genome-wide association studies have reported that polymorphisms within theITPKC gene were associated with susceptibility and severity of Kawasaki disease. IP3 binds to its receptor IP3R expressed on the endoplasmic reticulum membrane and causes the release of Ca2+ into the cytoplasm. Ca2+ mobilization mediates NLRP3 activation. Certain PAMPS are also capable of directly activating the NLRP3 inflammasome. Activation of the inflammasome results in the cleavage of pro-IL-1β into its biologically active form IL-1β, which shapes adaptive immune responses. IL-1β can enhance naive T cell survival and proliferation, via upregulation of the IL-2 receptor. Additionally, a role for IL-1R signaling in Th17 cell differentiation and homeostasis has been reported.Abbreviations: ER, endoplasmic reticulum; IL, interleukin; IP3, inositol 1,4,5-triphosphate; IP4, inositol tetrakisphosphate; ITPKC, inositol-triphosphate 3-kinase C; NLRP3, NOD-like receptor family pyrin domain containing 3; PAMPS, pathogen-associated molecular patterns; PIP2, phosphatidylinositol 4,5-bisphosphate; PLC, phospholipase C; ROS, reactive oxygen species; TLR, Toll-like receptor.
Similar articles
- Kawasaki disease: a comprehensive review of treatment options.Patel RM, Shulman ST.Patel RM, et al.J Clin Pharm Ther. 2015 Dec;40(6):620-5. doi: 10.1111/jcpt.12334. Epub 2015 Nov 7.J Clin Pharm Ther. 2015.PMID:26547265Review.
- Current pharmacological intervention and development of targeting IVIG resistance in Kawasaki disease.Zhang RL, Lo HH, Lei C, Ip N, Chen J, Law BY.Zhang RL, et al.Curr Opin Pharmacol. 2020 Oct;54:72-81. doi: 10.1016/j.coph.2020.08.008. Epub 2020 Sep 18.Curr Opin Pharmacol. 2020.PMID:32956895Free PMC article.Review.
- A low-frequency IL4R locus variant in Japanese patients with intravenous immunoglobulin therapy-unresponsive Kawasaki disease.Amano Y, Akazawa Y, Yasuda J, Yoshino K, Kojima K, Kobayashi N, Matsuzaki S, Nagasaki M, Kawai Y, Minegishi N, Ishida N, Motoki N, Hachiya A, Nakazawa Y, Yamamoto M, Koike K, Takeshita T.Amano Y, et al.Pediatr Rheumatol Online J. 2019 Jul 3;17(1):34. doi: 10.1186/s12969-019-0337-2.Pediatr Rheumatol Online J. 2019.PMID:31269967Free PMC article.
- Kawasaki disease: aetiopathogenesis and therapeutic utility of intravenous immunoglobulin.Galeotti C, Bayry J, Kone-Paut I, Kaveri SV.Galeotti C, et al.Autoimmun Rev. 2010 Apr;9(6):441-8. doi: 10.1016/j.autrev.2009.12.004. Epub 2010 Jan 13.Autoimmun Rev. 2010.PMID:20004744Free PMC article.Review.
- Th17- and Treg-related cytokine and mRNA expression are associated with acute and resolving Kawasaki disease.Guo MM, Tseng WN, Ko CH, Pan HM, Hsieh KS, Kuo HC.Guo MM, et al.Allergy. 2015 Mar;70(3):310-8. doi: 10.1111/all.12558. Epub 2015 Jan 14.Allergy. 2015.PMID:25585854
Cited by
- Effects of changes on gut microbiota in children with acute Kawasaki disease.Shen J, Ding Y, Yang Z, Zhang X, Zhao M.Shen J, et al.PeerJ. 2020 Aug 6;8:e9698. doi: 10.7717/peerj.9698. eCollection 2020.PeerJ. 2020.PMID:33005487Free PMC article.
- Adeno-associated Virus Vector-mediated Interleukin-10 Induction Prevents Vascular Inflammation in a Murine Model of Kawasaki Disease.Nakamura J, Watanabe S, Kimura H, Kobayashi M, Karasawa T, Kamata R, Usui-Kawanishi F, Sadatomo A, Mizukami H, Nagi-Miura N, Ohno N, Kasahara T, Minota S, Takahashi M.Nakamura J, et al.Sci Rep. 2018 May 15;8(1):7601. doi: 10.1038/s41598-018-25856-0.Sci Rep. 2018.PMID:29765083Free PMC article.
- A comparison of the predictive validity of the combination of the neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio and other risk scoring systems for intravenous immunoglobulin (ivig)-resistance in Kawasaki disease.Takeshita S, Kanai T, Kawamura Y, Yoshida Y, Nonoyama S.Takeshita S, et al.PLoS One. 2017 May 23;12(5):e0176957. doi: 10.1371/journal.pone.0176957. eCollection 2017.PLoS One. 2017.PMID:28542183Free PMC article.
- Autoimmune and inflammatory diseases following COVID-19.Galeotti C, Bayry J.Galeotti C, et al.Nat Rev Rheumatol. 2020 Aug;16(8):413-414. doi: 10.1038/s41584-020-0448-7.Nat Rev Rheumatol. 2020.PMID:32499548Free PMC article.
- Predictive value of brachial artery flow-mediated dilation on coronary artery abnormality in acute stage of Kawasaki disease.Wen Y, Wang X, Guo Y, Jin M, Xi J, Chen T, Shi K, Lu Y.Wen Y, et al.Sci Rep. 2021 Apr 14;11(1):8162. doi: 10.1038/s41598-021-87704-y.Sci Rep. 2021.PMID:33854198Free PMC article.
References
- Kawasaki T. Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children. Arerugi. 1967;16:178–222. (in Japanese) - PubMed
- Fraison J.B. Kawasaki disease in adults: observations in France and literature review. Autoimmun. Rev. 2016;15:242–249. - PubMed
- Onouchi Y. Genetics of Kawasaki disease: what we know and don’t know. Circ. J. 2012;76:1581–1586. - PubMed
Publication types
MeSH terms
Related information
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical